Mayo Clinic Names AI-Focused Callstrom as CEO
Vendors and service firms working with Mayo Clinic should watch how the new leader's technology priorities affect purchasing from January 2027.
Updated on Nov. 13, 2026 in People
Live Poll
Do you trust doctors and hospitals to use AI in ways that help patients?
Mayo Clinic's Board of Trustees has selected Dr. Matthew Callstrom as the institution's next president and CEO, effective January 1, 2027. He succeeds Dr. Gianrico Farrugia, who steps down at the end of 2026 after serving since January 2019.
Why it matters
Leadership transitions at large health systems shape strategic priorities, capital allocation, and the adoption pace of new technology across a major regional employer. Callstrom's background in strategy and AI integration signals that digital tools and operational modernization are likely to remain central to the organization's direction.
Callstrom has nearly 25 years of experience at Mayo Clinic, having joined in 2002, while Farrugia has led the organization since January 2019. The transition takes effect January 1, 2027, giving both leaders a short overlap period through December 31, 2026.
The players
Mayo Clinic
A Rochester, Minnesota-based nonprofit health system and academic medical center, one of the largest integrated healthcare providers in the United States, combining clinical care, research, and medical education.
Dr. Matthew Callstrom
A physician-scientist and radiologist with nearly 25 years at Mayo Clinic, now selected to lead the health system as president and CEO, with a background in strategy and AI integration.
Dr. Gianrico Farrugia
Mayo Clinic's president and CEO since January 2019, who steps down at the end of 2026 after leading the institution through roughly eight years of operations.
The details
The Board of Trustees made the selection, and the choice was announced Friday, November 13, 2026. Callstrom is a physician-scientist and radiologist who has served on the Board of Governors and Board of Trustees. He currently serves as medical director for Mayo Clinic's Strategy and AI Program and has helped integrate artificial intelligence into the clinic's medical practice. He previously served as interim chief strategy officer and as chair of the Radiology Department.
Timeline
January 2019: Farrugia began serving as Mayo Clinic president and CEO.
2002: Callstrom joined Mayo Clinic.
November 13, 2026: The Board of Trustees announced Callstrom's selection.
December 31, 2026: Farrugia's tenure as president and CEO ends.
January 1, 2027: Callstrom assumes the role of president and CEO.
Market Landscape
Mayo Clinic's leadership succession follows the internal-promotion pattern that has marked its executive transitions, keeping continuity within the institution. The emphasis on AI integration places Mayo among health systems prioritizing digital operations as a competitive factor in patient care and research.
Operators of vendors, suppliers, and service firms that work with Mayo Clinic should track whether Callstrom's AI and strategy priorities translate into new procurement or technology-partner opportunities. Businesses with ties to the health system should monitor the transition period through year-end 2026 for any shifts in purchasing or contracting.
The takeaway
Watch how the new CEO's AI and strategy background shapes Mayo Clinic's purchasing and partnership decisions in 2027. Operators pursuing health-system contracts should review vendor qualification requirements as the leadership transition takes effect.
What happens next
Callstrom assumes the role of president and CEO on January 1, 2027, and Farrugia's tenure ends December 31, 2026.
Further reading
For more on the executives shaping regional employers, explore People coverage in the Rochester business landscape.
Live Poll
Do you trust doctors and hospitals to use AI in ways that help patients?
